Label (Lbl721621594)
Oxcarbazepine Tablet, Film Coated
Product Images NDC 72162-1594
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 72162-1594). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Oxcarbazepine 01)
Figure 1 (Oxcarbazepine 02)
The given text mentions the term "Exit rate" and indicates the use of a log-rank test with a p-value of 0.0001. It also includes a table showing some data related to "Time on trial" for both Day 2 and Day 11. Additionally, it specifies a "Treatment Group" involving the use of Oxcarbazepine and Placebo.*
Figure 2 (Oxcarbazepine 03)
Seizure rate was analyzed using a log-rank test. The p-value obtained was 0.046, suggesting a statistically significant difference. The data presented in the table shows the number of days from the first dose to the first seizure in the treatment groups. The treatment groups included Oxcarbazepine and Placebo.*
Figure 3 (Oxcarbazepine 04)
Figure 4 (Oxcarbazepine 05)
The given text is not readable. Therefore, the description is "Not available".*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
